GE Healthcare Tops Q2 Earnings Estimates, Reaffirms 2026 Outlook

GE Healthcare reported second-quarter 2026 results that exceeded analyst expectations. Adjusted earnings per share came in at $1.13, above the consensus estimate of $1.04. Adjusted EBIT reached $750 million, beating the expected $733.7 million, while revenue totaled $5.30 billion, slightly ahead of the $5.27 billion forecast.

The company also reaffirmed its full-year 2026 guidance. It continues to project adjusted EPS in the range of $4.80 to $5.00, compared to a consensus of $4.88. The adjusted margin is expected to be between 15.1% and 15.4%, in line with the midpoint estimate of 15.4%. Organic revenue growth is forecast at 3% to 4%, versus expectations of 3.66%.

With all key metrics above estimates and full-year targets confirmed, the results signal steady performance for the medical technology firm.